Dow Jones

39 127,80

0,04%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

DRTX

(MM) (DRTX)

(MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:DRTX

1 2 3 4 5 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
12/12/2014	20h42	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:DRTX	(MM)
28/11/2014	15h56	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:DRTX	(MM)
19/11/2014	23h44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRTX	(MM)
19/11/2014	22h58	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:DRTX	(MM)
19/11/2014	12h01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:DRTX	(MM)
17/11/2014	22h47	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:DRTX	(MM)
17/11/2014	22h35	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:DRTX	(MM)
17/11/2014	22h18	Edgar (US Regulatory)	(25-NSE)	NASDAQ:DRTX	(MM)
17/11/2014	21h26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DRTX	(MM)
17/11/2014	14h33	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:DRTX	(MM)
17/11/2014	14h23	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:DRTX	(MM)
17/11/2014	14h00	PR Newswire (US)	Actavis Successfully Completes Durata Therapeutics, Inc. Tender Offer	NASDAQ:DRTX	(MM)
07/11/2014	13h50	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:DRTX	(MM)
31/10/2014	21h15	PR Newswire (US)	Actavis and Durata Therapeutics Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Durata	NASDAQ:DRTX	(MM)
17/10/2014	22h48	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:DRTX	(MM)
17/10/2014	18h12	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:DRTX	(MM)
14/10/2014	18h36	Business Wire	INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Durata Therapeutics Inc. Concerning...	NASDAQ:DRTX	(MM)
11/10/2014	13h05	Business Wire	SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Durata Therapeutics, Inc. in Connection with the Sale of t...	NASDAQ:DRTX	(MM)
11/10/2014	00h45	PR Newswire (US)	DURATA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Durata Therapeutics Inc. (DRTX) Over the Propos...	NASDAQ:DRTX	(MM)
10/10/2014	23h31	Business Wire	DURATA THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout	NASDAQ:DRTX	(MM)
10/10/2014	23h25	Business Wire	SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Durata Therapeutics, Inc. And Encourages ...	NASDAQ:DRTX	(MM)
10/10/2014	02h20	PR Newswire (US)	Harwood Feffer LLP Announces Investigation of Durata Therapeutics, Inc.	NASDAQ:DRTX	(MM)
08/10/2014	12h07	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:DRTX	(MM)
08/10/2014	00h29	PR Newswire (US)	Lifshitz & Miller Law Firm Announces Investigation of Altair Nanotechnologies, Inc., CareFusion, Durata Therapeutics, Inc., E...	NASDAQ:DRTX	(MM)
07/10/2014	22h34	PR Newswire (US)	INVESTOR ALERT: The Law Offices of Vincent Wong Investigates the Board of Directors of Durata Therapeutics Inc. Regarding the...	NASDAQ:DRTX	(MM)
07/10/2014	16h45	PR Newswire (US)	Ryan & Maniskas, LLP Announces Investigation of Durata Therapeutics, Inc.	NASDAQ:DRTX	(MM)
07/10/2014	01h15	Business Wire	DURATA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Durata Therapeutics Inc. (DRTX) over the Propos...	NASDAQ:DRTX	(MM)
07/10/2014	00h18	Dow Jones News	U.S. Hot Stocks: Hot Stocks to Watch	NASDAQ:DRTX	(MM)
06/10/2014	23h11	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:DRTX	(MM)
06/10/2014	19h22	Business Wire	Glancy Binkow & Goldberg LLP is Investigating Durata Therapeutics, Inc. Board of Directors	NASDAQ:DRTX	(MM)